The new guidelines provide updated diagnostic and therapeutic strategies for both mucocutaneous and invasive candidiasis.

A drug-resistant fungus, Candida Auris, is spreading rapidly in U.S. hospitals, posing a severe threat to patients who need invasive medical equipment ...

In the complex ecosystem of the human body, yeast exists as a quiet inhabitant, typically harmless but capable of causing ...

Diseases caused by Candida are among the most common fungal infections worldwide. The new guideline was developed over four years by a team of more than one hundred experts from 35 countries.

A record 384 New Jersey residents contracted a deadly fungal pathogen last year. The fungus, Candida auris, kills about a ...

Genomic sequencing has revealed that individual strains of life-threatening, antibiotic-resistant bacteria and Candida auris ...

A team of international clinical experts led by Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne, including ...

Their cost may limit their use as initial therapy for patients with fungemia in medical centers or intensive care units with a high rate of triazoleresistant Candida infections. Invasive fungal ...

Candida infections in the ICU may be i ... Laboratory testing to certify the eradication of the fungus is not suggested. Relapses due to incomplete eradication and lack of sterilization of ...